Growth of 40% per annum continues for AFT Pharmaceuticals in the Australasian market (Australia and NZ) with sales for this year due to break $22 million per annum.
AFT Group Sales Growth continues at +40%
Similar articles
AFT Pharmaceuticals breaks through $100 million revenue and posts record earnings
Highlights
Read more
AFT appoints Anita Baldauf as a director
AFT Pharmaceuticals (NZX; AFT, ASX; AFP) has today appointed Anita Baldauf as a non-executive director.
Read more
AFT picks up Supreme Business award
A Takapuna-based drug company claimed top honours at the 2011 Westpac Auckland North Business Awards at the competition’s annual Gala Dinner held last night.
Read more